Drug Type Fusion protein |
Synonyms |
Target |
Mechanism GPC3 modulators(Glypican-3 modulators), IFNA modulators(interferon alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
GPC3 Positive Neoplasms | IND Approval | US | 15 Jan 2024 |